Status: current, Primitive. Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3510299010 | Janus kinase inhibitor (disposition) | en | Fully specified name | Active | Case sensitive | SNOMED CT core |
| 3510300019 | Janus kinase inhibitor | en | Synonym | Active | Case sensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Janus kinase inhibitor | Is a | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fedratinib | Has disposition | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Upadacitinib | Has disposition | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Fedratinib hydrochloride | Has disposition | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Upadacitinib hemihydrate | Has disposition | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Ruxolitinib | Has disposition | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Janus kinase inhibitor | Has disposition | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Tofacitinib | Has disposition | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Tofacitinib citrate | Has disposition | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Baricitinib | Has disposition | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Ruxolitinib phosphate | Has disposition | True | Janus kinase inhibitor | Inferred relationship | Some |
Reference Sets
Qualifier value foundation reference set
FHIR